Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Henell

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Transplantation Proceedings|February 1, 1987
Donor specific transfusions: a five-year experience with alternative protocolsD J Norman, K Henell, L Fletcher, et al.
Transplantation Proceedings|April 1, 1987
A U.S. clinical study of Orthoclone OKT3 in renal transplantationD J Norman, C F Shield, J Barry, et al.
Nephron|January 1, 1987
Therapeutic use of OKT3 monoclonal antibody for acute renal allograft rejectionD J Norman, C F Shield, J M Barry, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1988
Early use of OKT3 monoclonal antibody in renal transplantation to prevent rejectionD J Norman, C F Shield, J Barry, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1988
The use of OKT3 in cadaveric renal transplantation for rejection that is unresponsive to conventional anti-rejection therapyD J Norman, J M Barry, W M Bennett, et al.
Transplantation Proceedings|February 1, 1991
OKT3 for induction immunosuppression in renal transplantation: a comparative study of high versus low dosesD J Norman, J M Barry, W M Bennett, et al.
The Journal of Pediatrics|July 1, 1987
OKT3 monoclonal antibody in pediatric kidney transplant recipients with recurrent and resistant allograft rejectionM R Leone, S R Alexander, J M Barry, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Transplantation Proceedings|February 1, 1987
Donor specific transfusions: a five-year experience with alternative protocolsD J Norman, K Henell, L Fletcher, et al.
Transplantation Proceedings|April 1, 1987
A U.S. clinical study of Orthoclone OKT3 in renal transplantationD J Norman, C F Shield, J Barry, et al.
Nephron|January 1, 1987
Therapeutic use of OKT3 monoclonal antibody for acute renal allograft rejectionD J Norman, C F Shield, J M Barry, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1988
Early use of OKT3 monoclonal antibody in renal transplantation to prevent rejectionD J Norman, C F Shield, J Barry, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1988
The use of OKT3 in cadaveric renal transplantation for rejection that is unresponsive to conventional anti-rejection therapyD J Norman, J M Barry, W M Bennett, et al.
Transplantation Proceedings|February 1, 1991
OKT3 for induction immunosuppression in renal transplantation: a comparative study of high versus low dosesD J Norman, J M Barry, W M Bennett, et al.
The Journal of Pediatrics|July 1, 1987
OKT3 monoclonal antibody in pediatric kidney transplant recipients with recurrent and resistant allograft rejectionM R Leone, S R Alexander, J M Barry, et al.
Pageof 1